The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer

Experimental Oncology

Volumn 31, Issue 1, 2009, Pages 37-42

  Gryshkova, V ^a   Goncharuk, I ^b   Gurtovyy, V ^c   Khozhayenko, Yu ^c   Nespryadko, S ^b   Vorobjova, L ^b   Usenko, V ^c   Gout, I ^a,d   Filonenko, V ^a   Kiyamova, R ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b NATIONAL CANCER INSTITUTE   (Ukraine)

^c Research and Production Center Medical Technologies   (Ukraine)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epithelial ovarian cancer; Phosphate transporter NaPi2b; Tumor markers

Indexed keywords

PROTEIN NAPI2B; SODIUM PHOSPHATE COTRANSPORTER; UNCLASSIFIED DRUG; PHOSPHATE TRANSPORTER; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; CYSTADENOMA; ENDOMETRIOID CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCINOUS CARCINOMA; OVARY CANCER; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADULT; AGED; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; NEOPLASM; OVARY TUMOR;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; OVARIAN NEOPLASMS; PHOSPHATE TRANSPORT PROTEINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 65549149073     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
2. Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351: 2519-2529
3. Bhoola S, Hoskins WJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006; 107: 1399-1410 (Pubitemid 44336908)
4. Ozols RF, Rubin SC, Thomas GM, Robboy SJ. Epithelial ovarian cancer. In: Hoskins WJ, Young RC, Markman M, Perez CA, Barakat R, Randall M, eds. Principles and Practice of Gynecologic Oncology. Philadelphia, PA: Lippincott Williams & Wilkins 2005; 895-988.
5. Zoloudek CF. Tumors of the ovary. In: Fletcher C. Diagnostic Histopathology of Tumors. New-York, NY: Churchill Livingstone, 3d ed.; 2007: 501-555
6. Auersperg N, Wong AS, Choi KC, et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255-288 (Pubitemid 32458162)
7. Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res 2008; 18: 538-548 (Pubitemid 351630950)
8. Yin BWT, Kiyamova R, Chua R, et al. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas; a new target for cancer immunotherapy. Cancer Immun [serial online] 2008; 8:3. URL: http://www.cancerimmunity.org/v8p3/080103.htm.
9. Mattes MJ, Look K, Furukawa K, et al. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res 1987; 47: 6741-6750 (Pubitemid 18019679)
10. Rubin SC, Kostakoglu L, Divgi C, et al. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer. Gynecol Oncol 1993; 51: 61-66 (Pubitemid 23339265)
11. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch - Eur J Physiol 2004; 447: 763-767 (Pubitemid 38241464)
12. Feild JA, Zhang L, Brun KA, et al. Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem Biophys Res Commun 1999; 258: 578-582 (Pubitemid 29290311)
13. Traebert M, Hattenhauer O, Murer H, et al. Expression of a type II sodium-phosphate cotransporter in murine type II alveolar epithelial cells. Am J Physiol 1999; 277: L868-73.
14. Frei P, Gao B, Hagenbuch B, et al. Identification and localization of sodium-phosphate cotransporters in hepatocytes and cholangiocytes of rat liver. Am J Physiol Gastrointest Liver Physiol 2005; 288: G771-8. (Pubitemid 40388189)
15. Huber K, Muscher A, Breves G. Sodium-dependent phosphate transport across the apical membrane of alveolar epithelium in caprine mammary gland. Comp Biochem Phys 2007; 146: 215-222
16. Homann V, Rosin-Steiner S, Stratmann T, et al. Sodium-phosphate cotransporter in human salivary glands: molecular evidence for the involvement of NPT2b in acinar phosphate secretion and ductal phosphate reabsorption. Arch Oral Biol 2005; 50: 759-768 (Pubitemid 40817367)
17. Rangel LB, Sherman-Baust CA, Wernyj RP, et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003; 22: 7225-7232
18. Kiyamova R, Gryshkova V, Ovcharenko G, et al. Development of monoclonal antibodies specific for the human sodium-dependent phosphate cotransporter NaPi2b. Hybridoma 2008; 27: 277-284
19. Siebert PD, Chenchik A. Modified acid guanidinium thiocyanate-phenol- chloroform RNA extraction method, which greatly reduces DNA contamination. Nucleic Acids Res 1993; 21: 2019-2020
20. Xu Y, Yeung C-H, Setiawan I, et al. Sodium-inorganic phosphate cotransporter NaPi-IIb in the epididymis and its potential role in male fertility studied in a transgenic mouse model. Biol Reprod 2003; 69: 1135-1141 (Pubitemid 37173843)
21. Lundquist P, Murer H, Biber J. Type II Na+-P cotransporters in osteoblast mineral formation; regulation by inorganic phosphate. Cell Physiol Biochem 2007; 19: 43-56. (Pubitemid 46270888)
22. Hilfiker H, Hattenhauer O, Traebert M, et al. Characterization of a new murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 1998; 95: 14564-14569 (Pubitemid 28549407)
23. Maki M, Hirota S, Kaneko Y, Morohoshi T. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies. Pathol Int 2000; 50: 531-535 (Pubitemid 30609860)
24. Blanchard A, Shiu R, Booth S, et al. Gene expression profiling of early involuting mammary gland reveals novel genes potentially relevant to human breast cancer. Front Biosci 2007; 12: 2221-2232
25. Gałȩza-Kulik M, Zebracka J, Szpak-Ulczok S, et al. Expression of selected genes involved in transport of ions in papillary thyroid carcinoma. Endokrynol Pol 2006; 57: 26-31 (in Polish).
26. Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79: 650-656 (Pubitemid 44452742)
27. Makar AP, Beakeland M, Trope CG, et al. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage lll ovarian cancer. Gynecol Oncol 1995; 56: 175-180
28. Shimuzu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system of ovarian epithelial carcinoma. 1. Prognostic significance of histopathologic features - problems involved in the architectural grading system. Gynecol Oncol 1998; 70: 2-12.
29. Seidman JD, Kurman RJ. Pathology of ovarian carcinoma. Hematol Oncol Clin North Am 2003; 17: 909-925